© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Aimei Health Technology Co., Ltd (AFJK) shows an Average True Range (ATR) of 16.83 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 166.46K, indicating liquidity. These fundamental metrics provide insight into AFJK's underlying financial health and market activity.
Aimei Health Technology Co., Ltd (AFJK) technical indicators as of December 30, 2025: the SMA 20 is 39.65%, SMA 50 at 123.43%, and SMA 200 at 236.45%. The RSI 14 value is 56.64, suggesting its current momentum. These technical analysis signals help assess AFJK's price trends and potential future movements.
Aimei Health Technology Co., Ltd (AFJK) stock performance overview as of December 30, 2025: The 52-week high is $98.15 (currently -55.53% below), and the 52-week low is $6.75 (currently 546.67% above). Over the past year, AFJK's performance is N/A, compared to the S&P 500's 10.62% change.
According to market data, Aimei Health Technology Co., Ltd (AFJK) stock's recent performance metrics show that over the last month, AFJK is 285.6%, with a Year-to-Date (YTD) performance of 307.94%. Over the past year, the stock has seen a N/A change. These figures summarize AFJK's price movements across various periods, reflecting its historical returns.
According to current financial data, AFJK stock's P/E (TTM) ratio is 125.12, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 47.79. Key valuation ratios for AFJK, including P/S (N/A), P/B (4.19), and P/FCF (-375.84), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.